Taysha Gene Therapies, Inc. (TSHA) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Responder Rate Gained or Regained at Least One Developmental Milestone | 100.00 percent | FY2025-Q4 |
Back to TSHA overview · TSHA earnings · TSHA holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.